• admin@ataxiatelangiectasia.es
Ataxia Telangiectasia
  • Home
  • Was ist A-T?
  • Nachricht
  • Ataxia-telangiectasia: Immunodeficiency and survival.
  • ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
  • In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia.
  • Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial.
  • Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.
  • Neurovisual Assessment in Children with Ataxia Telangiectasia.
  • Novel compound heterozygous mutations in a child with Ataxia-Telangiectasia showing unrelated cerebellar disorders.

Language

  Deutsch (Deutschland)
  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

Ataxia Telangiectasia
  • Home
  • Was ist A-T?
  • Nachricht
  • admin@ataxiatelangiectasia.es